Iovance Biotherapeutics, Inc.
IOVA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $158 | $132 | $172 | $116 |
| Short-Term Investments | $143 | $169 | $188 | $208 |
| Receivables | $67 | $60 | $71 | $69 |
| Inventory | $52 | $50 | $66 | $52 |
| Other Curr. Assets | $10 | $12 | $16 | $12 |
| Total Curr. Assets | $429 | $423 | $513 | $457 |
| Property Plant & Equip (Net) | $175 | $172 | $162 | $164 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $285 | $296 | $285 | $282 |
| Long-Term Investments | $6 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $9 | $16 | $6 | $7 |
| Total NC Assets | $476 | $485 | $454 | $453 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $905 | $907 | $967 | $910 |
| Liabilities | – | – | – | – |
| Payables | $31 | $32 | $28 | $28 |
| Short-Term Debt | $7 | $8 | $9 | $13 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $87 | $89 | $85 | $82 |
| Total Curr. Liab. | $126 | $129 | $123 | $122 |
| LT Debt | $45 | $45 | $44 | $45 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $32 | $35 | $32 | $32 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $77 | $80 | $76 | $78 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $45 | $52 | $53 | $57 |
| Total Liabilities | $203 | $209 | $199 | $200 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$2,704 | -$2,612 | -$2,501 | -$2,385 |
| AOCI | $16 | $21 | $6 | -$1 |
| Other Equity | $3,390 | $3,290 | $3,262 | $3,096 |
| Total Equity | $702 | $698 | $768 | $710 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $905 | $907 | $967 | $910 |
| Net Debt | -$106 | -$79 | -$118 | -$57 |